Comparing HM patients with BT infection to those without a history of COVID-19 or BT infection (n = 27), there was no difference in the frequency of activated CD4+ T cells and CD8+ T cells (Figure 4A and 4B, respectively) at V1. This evidence concerns the gene CD8A and COVID-19.